Acute Rheumatic Fever Diagnosis and Management

Clinical Presentation and Diagnosis

• The American Heart Association recommends that a diagnosis of acute rheumatic fever (ARF) be considered in patients presenting with a combination of major and minor manifestations, including carditis, polyarthritis, erythema marginatum, and subcutaneous nodules, following a group A streptococcal pharyngitis, with a latency period of 14-21 days 1, 2.
• The Jones diagnostic criteria include major manifestations such as carditis, characterized by a new heart murmur and pericardial friction rub, indicating pancarditis, and minor manifestations such as fever and malaise, which are consistent with a systemic inflammatory response 1, 3.
• Echocardiography with Doppler should be performed immediately to fully characterize the valvulitis, assess for pathological mitral and/or aortic regurgitation, and document baseline cardiac status, as recommended by the American College of Cardiology 1.

Laboratory Findings and Diagnostic Confirmation

• Elevated or rising anti-streptolysin O (ASO) titers and/or anti-DNase B antibodies are expected in ARF, along with evidence of recent group A streptococcal infection, elevated acute phase reactants (ESR and CRP), and possible prolonged PR interval on ECG, according to the American Heart Association 2, 4.
• The American College of Cardiology recommends that ASO titers and anti-DNase B antibodies be used to confirm a recent group A streptococcal infection, with ASO titers elevated in approximately 80% of ARF cases, and peak levels occurring 3-6 weeks after pharyngitis 2, 4.

Pathogenesis and Progression to Chronic Disease

• The American Heart Association states that ARF results from molecular mimicry, whereby antibodies and T-cells generated against group A streptococcal M-protein cross-react with structurally similar human cardiac tissue antigens, triggering an autoimmune inflammatory response in genetically susceptible individuals, with a latency period of 14-21 days 2, 5.
• Recurrent GAS infections lead to repeated ARF episodes, causing progressive valvular damage, and chronic inflammation results in commissural fusion, leaflet thickening, chordal shortening, and eventual calcification, leading to rheumatic heart disease with stenosis and/or regurgitation, as described by the American College of Cardiology 6.

Management and Prevention

• The American Heart Association recommends immediate penicillin therapy to eradicate residual GAS, even if throat culture is negative, and lifelong secondary prophylaxis with benzathine penicillin G to prevent recurrent ARF and progressive cardiac damage, especially in patients with carditis and likely residual heart disease 7.
• Anti-inflammatory therapy with salicylates or corticosteroids (if severe carditis) is recommended for symptom management, according to the American College of Cardiology 7.

Diagnostic Challenges and Management of Acute Rheumatic Fever

Core Diagnostic Considerations

• Approximately 15% of school-age children are asymptomatic GAS carriers, making it challenging to distinguish between true infection and carriage with concurrent viral pharyngitis, according to the American Heart Association 8, 9
• At least one-third of acute rheumatic fever cases result from inapparent streptococcal infections, meaning patients never had recognized pharyngitis, making primary prevention impossible in these scenarios, as noted by the American Heart Association 10, 9
• The GAS infection need not be symptomatic to trigger rheumatic fever, further obscuring the diagnostic pathway, as stated by the American Heart Association 11

Distinguishing ARF from Mimicking Conditions

• Significant overlap exists with Lyme disease, serum sickness, drug reactions, and post-streptococcal reactive arthritis, making differentiation challenging, however, Group C and G streptococcal pharyngitis can present identically to GAS pharyngitis but do NOT cause acute rheumatic fever, according to the American Heart Association 8, 12

Preventing Overdiagnosis and Underdiagnosis

• Throat swab specimens should be obtained from ALL household contacts of a child with acute rheumatic fever, and positive contacts should be treated regardless of symptoms, as recommended by the American Heart Association 9, 13

Critical Management Implications

• Continuous antimicrobial prophylaxis is required rather than episodic treatment because recurrent ARF can occur even with appropriate treatment of symptomatic GAS infections, as stated by the American Heart Association 11
• Patients with previous ARF are at high risk for recurrent attacks when GAS pharyngitis develops, with each recurrence potentially worsening rheumatic heart disease, according to the American Heart Association 11, 12
• The duration of prophylaxis depends on cardiac involvement, with the American Heart Association recommending 5 years or until age 21 (no carditis), 10 years or until age 21 (carditis without residual disease), or 10 years or until age 40—sometimes lifelong (carditis with residual valvular disease) 11, 12

Management and Prevention of Acute Rheumatic Fever (cited evidence)

Diagnosis and Initial Evaluation

• In a school‑age child with fever, migratory arthritis, carditis, rash, or chorea after a recent sore throat, immediate laboratory confirmation of recent Group A streptococcal (GAS) infection, prompt echocardiography to detect overt or subclinical carditis, and early initiation of penicillin therapy are required, followed by continuous secondary prophylaxis to prevent recurrent attacks and progressive cardiac damage. 14
• Approximately 15 % of school‑age children are asymptomatic GAS carriers, which can complicate differentiation between true infection and carriage when viral pharyngitis is present. 14

Therapeutic Interventions

Eradication of Residual GAS

• A full therapeutic course of penicillin should be administered immediately at diagnosis, even if the throat culture is negative, to eradicate any residual streptococci. 15

Anti‑Inflammatory Therapy

• Acetylsalicylic acid (aspirin) is recommended for the treatment of arthritis and mild carditis because rheumatic fever arthritis responds rapidly to aspirin, unlike post‑streptococcal reactive arthritis. 16

Management of Post‑Streptococcal Reactive Arthritis (PSRA)

• PSRA differs from acute rheumatic fever: it appears ≈ 10 days after pharyngitis (rather than 14‑21 days), does not respond readily to aspirin, tends to be cumulative and persistent, and may involve small joints or the axial skeleton. 16
• Patients with PSRA should be observed for several months for any evidence of carditis and may receive secondary prophylaxis for up to 1 year, although the effectiveness of this prophylaxis is not well established. 16

Secondary Prophylaxis

• Recurrent rheumatic fever occurs in 18.7 % of patients despite prophylaxis recommendations, underscoring the need for continuous antimicrobial secondary prophylaxis. 15
• Benzathine penicillin G 1,200,000 units intramuscularly every 4 weeks (600,000 units for children < 27 kg) is the gold‑standard regimen and is roughly 10 times more effective than oral antibiotic regimens. 15
• Prophylaxis duration is stratified by cardiac involvement:
  
  • No carditis: 5 years or until age 21 (whichever is longer). 15
  • Carditis without residual valvular disease: 10 years or until age 21 (whichever is longer). 15
  • Carditis with residual valvular disease: 10 years or until age 40 (whichever is longer), often lifelong. 15

Household Contact Management

• Throat swab specimens should be obtained from all household contacts, and any positive contacts should be treated regardless of symptoms to prevent transmission and potential development of rheumatic fever in genetically susceptible family members. 14